Cargando…
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
Macrophages are key immune cells found in atherosclerotic plaques and critically shape atherosclerotic disease development. Targeting the functional repertoire of macrophages may hold novel approaches for future atherosclerosis management. Here, we describe a previously unrecognized role of the epig...
Autores principales: | Hoeksema, Marten A, Gijbels, Marion JJ, Van den Bossche, Jan, van der Velden, Saskia, Sijm, Ayestha, Neele, Annette E, Seijkens, Tom, Stöger, J Lauran, Meiler, Svenja, Boshuizen, Marieke CS, Dallinga-Thie, Geesje M, Levels, Johannes HM, Boon, Louis, Mullican, Shannon E, Spann, Nathanael J, Cleutjens, Jack P, Glass, Chris K, Lazar, Mitchell A, de Vries, Carlie JM, Biessen, Erik AL, Daemen, Mat JAP, Lutgens, Esther, de Winther, Menno PJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197860/ https://www.ncbi.nlm.nih.gov/pubmed/25007801 http://dx.doi.org/10.15252/emmm.201404170 |
Ejemplares similares
-
Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
por: Neele, Annette E., et al.
Publicado: (2021) -
Molecular Pathways Regulating Macrophage Polarization: Implications for Atherosclerosis
por: Hoeksema, Marten A., et al.
Publicado: (2012) -
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016) -
Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice
por: Theelen, Thomas L., et al.
Publicado: (2015) -
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
por: Lutgens, Esther, et al.
Publicado: (2010)